Dr. Collier’s research interests include immunosuppressive agents and post-transplant complications such as hypertension, infection, or dyslipidemia. Research activities include oral beclomethasone use in small intestinal transplant recipients, and hepatitis B immune globulin to prevent recurrent hepatitis B in liver transplant recipients.